JAFRAL at ESCMID 2026
We are pleased to announce that JAFRAL will be attending ESCMID 2026, organized by the European Society of Clinical Microbiology and Infectious Diseases.
During the congress, our CEO, Dr. Frenk Smreakr and our COO, Dr. Barbara Hubad, will be available to meet with attendees and engage in discussions on key topics, including:
- Personalized phage‑based solutions
- Targeted phage treatment approaches
- Applications of magistral phage therapy
We look forward to connecting with clinicians, researchers, and partners who share a commitment to advancing innovative antimicrobial strategies and shaping the future of phage therapy through collaboration and real‑world clinical practice.
We invite you to visit us during the meeting and join the conversation.
